Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Manuel | 2021
l'approvisionnement plus sécuritaire, à propos des pharmaciens
This research aimed to examine the prevalence of polysubstance use in an opioid use disorder treatment trial population and polysubstance use's association with opioid relapse and craving.
Original research | 2022
Illegal drugs, Transitions in care/treatment, About PWUD, Outcomes
Did pandemic disruptions in filled buprenorphine and extended-release naltrexone prescriptions for opioid use disorder (OUD) differ by race and ethnicity or insurance status and payer type?
Original research | 2022
Equity, Substitution/OAT
Book | 2016
Harm reduction
The aim of this presentation is to examine the safety profile of injectable
hydromorphone and diacetylmorphine by analyzing rates of adverse
Slide deck | 2018
Safer supply, Evidence base, Overdose, Outcomes
Guide or handbook | 2018
Peer/PWLLE program involvement, About PWUD
Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo.
Original research | 2009
Stimulants, Illegal drugs, Outcomes
Lit review | 2015
Peer/PWLLE program involvement, Barriers and enablers
Manuel | 2019
site de consommation supervisée / centre de prévention des surdoses
Guidelines | 2019
Clinical guidance, About prescribers, Injecting drugs, Safer supply
Guide or handbook | 2020
Clinical guidance, Illegal drugs, About prescribers
Lit review | 2012
Stimulants, About prescribers, Clinical guidance
Commentary | 2021
Peer/PWLLE program involvement, About PWUD
We examined take-home naloxone (THN) program participants to 1) describe those that return for refills, specifically those that reported multiple use (supersavers), and 2) to examine what rescuer c
Original research | 2022
Harm reduction, About PWUD
The objectives of this analysis were to measure the impact of baseline fentanyl exposure on initiation and discontinuation of MOUD among individuals with prescription-type opioid use disorder (POUD
Original research | 2022
About PWUD, Transitions in care/treatment, Substitution/OAT
The purpose of the current study was to mimic the experience of an LGBTQ-identified individual searching for LGBTQ-specific OUD treatment services, using the SAMHSA National Directory of Drug and A
Original research | 2022
2SLGBTQI+
In the context of the ongoing overdose crisis, a stark increase in toxic drug deaths from the unregulated street supply accompanied the onset of the COVID-19 pandemic.
Original research | 2022
Policy/Regulatory, About prescribers, Evidence base, Advocacy, Safer supply, Barriers and enablers
The objectives of this study are to (1) identify changes introduced to OAT clinical guidelines in Ireland during the pandemic; and (2) develop consensus on whether the new recommendations should be
Original research | 2022
Policy/Regulatory, Clinical guidance
